![logo](/logos/RLF.SW.webp)
Relief Therapeutics Holding AG
SIX:RLF.SW
2.15 (CHF) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Relief Therapeutics Holding AG |
Symbool | RLF.SW |
Munteenheid | CHF |
Prijs | 2.15 |
Beurswaarde | 23,679,726 |
Dividendpercentage | 0% |
52-weken bereik | 1.055 - 3.535 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jack Weinstein M.B.A. |
Website | https://www.relieftherapeutics.com |
An error occurred while fetching data.
Over Relief Therapeutics Holding AG
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)